Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116103254B reveals stable enzyme mutants for UDCA. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112299962A reveals a novel supported chiral phosphoric acid catalyst for high-yield citral intermediate production, offering significant cost reduction and equipment longevity.
Patent CN109232220B details a novel chiral resolution method offering high purity and scalable production for pharmaceutical intermediate supply chains.
Patent CN108997376B reveals high-purity sulbactam acid production via recycling. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced resolution technology for Edoxaban precursor ensuring >99% ee. Optimized for cost-effective API manufacturing and reliable supply chain continuity.
This patent details a novel synthesis route for Amino K Acid reducing raw material consumption and waste. It offers significant supply chain stability and cost advantages for dye manufacturers seeking reliable partners.
Advanced patent CN104961675A enables safer isavuconazole intermediate production. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Advanced hydrolysis method for 3-(3-phenylsulfamoyl-phenyl)-acrylic acid. High-yield process for Belinostat intermediates ensuring supply chain stability.
Patent CN104230839A reveals a microchannel reactor method for high-purity benzisothiazolinone derivatives offering significant supply chain and cost advantages for global manufacturers.
Patent CN101100428A details a green boric acid-catalyzed route for high-purity chiral diethyl tartrate, offering cost reduction and zero-discharge manufacturing for pharma intermediates.
Patent CN108976129A details a high-yield route for flumioxazin intermediates ensuring cost reduction and supply reliability for international agrochemical manufacturing partners.
Novel route for 3-amino-7-chloroquinoline via Curtius rearrangement offers high yield and scalable production for antimalarial drug intermediates.
Patent CN104016875B details a novel synthesis for PBDE metabolite standards. This report analyzes cost reduction and supply chain reliability for high-purity specialty chemical manufacturing.
Novel sulfonic acid salt intermediates for antifolate agents. Enhanced stability and scalability for pharmaceutical manufacturing.
Patent CN104945308B details a novel catalytic reduction method offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Novel copper-catalyzed route for Rabociclib intermediate offers high purity and cost-effective manufacturing solutions for pharmaceutical supply chains globally.
Patent CN110305010B details a high-yield Grignard carboxylation route for 2,5-dimethylphenylacetic acid, eliminating toxic cyanides and noble metal catalysts for cost-effective manufacturing.
Patent CN111057052B enables selective synthesis. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturers.
Patent CN102827002A details a robust total synthesis of Salvianolic Acid A, offering a stable alternative to plant extraction for reliable pharmaceutical intermediate supply chains.
Patent CN118638002A details a green synthesis route for 2-propyl-4-pentenoic acid, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.